Results

Total Results: 904 records

Showing results for "author year description".

441. Disposition of Comments Report for Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
     October 23, 2014 - The characteristics of the studies are included but further description on the imaging criteria used

442. Microsoft Word - finbody.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-artery-stenosis_research-2007.pdf
     January 01, 2007 - The findings and conclusions in this document are those of the author(s), who are responsible for its … The grades provide a shorthand description of the strength of evidence supporting the major questions … Description of the comparative studies Nine other studies compared various interventions in randomized … Stent revascularization for atherosclerotic renal artery stenosis. 1-year clinical follow-up. … Predictors for clinical success at one year following renal artery stent placement.

443. Making Healthcare Safer IV: Interventions to Prevent Nonventilator Hospital-acquired Pneumonia (NV-HAP) for Inpatients (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-iv-nv-hap-protocol.pdf
     August 05, 2024 - ≥100 patients in each arm • Cross-sectional studies • Case series • Case reports Publication Year … Information will be organized according to the review and contextual questions, and will include author … , year, study design, care setting, patient population, characteristics of the PSPs used to prevent … prevalence, timing, severity), implementation barriers and facilitators, required resources, and description

444. Renal-Cancer Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/renal-cancer_research-protocol.pdf
     April 20, 2015 - resected tumors.[1, 3] It is known that kidney cancer affects approximately 65,000 new patients each year … stage T1N0M0, ≤ 7 cm in diameter; stage T2N0M0, > 7 cm in diameter) have excellent outcomes with 5-year … All extirpative options are associated with an excellent oncologic cure rate (> 95% 5-year disease … exclude studies that: do not report the health outcomes of interest OR do not give an adequate description … more Every other uncontrolled study will get listed in the appendix with the following data: Author

445. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-medical-update_research-protocol.pdf
     February 16, 2016 - Published online: February 16, 2016 2   cohort8 and an estimated additional cost of $17,000 per year … Interventions to Target Sensory Challenges As noted, we define sensory challenges in line with the broad description … severity, treatment history); diagnostic and/or assessment methods; intervention characteristics (e.g., description … Developmental Disabilities Monitoring Network Surveillance Year Principal I, Centers for Disease C, … Age and IQ at intake as predictors of placement for young children with autism: a four- to six-year

446. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/disparities-quality-improvement_research-protocol.pdf
     February 23, 2012 - may vary by key question as appropriate, but the tables will contain some common elements, such as author … , year of publication, study location (e.g., city, state) and time period, population description, … limiting the ability to apply interventions to other populations or other settings, such as inadequate description … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

447. EHC Protocol: Addressing Social Isolation To Improve Health of Older Adults: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-sepsis.pdf
     July 01, 2023 - Control and Prevention (CDC) estimate that at least 1.7 million adults in America develop sepsis every year … Information will be organized according to the review questions, and will include author, year, study … rationale for the PSP, outcomes, implementation barriers and facilitators, required resources, and description

448. Autism Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_surveillance.pdf
     October 01, 2012 - Gains were maintained at 1 year f/u. … First Author & Affiliation: Klintwall, Lars. 24. … First Author & Affiliation: Strauss, Kristin. 26. … Evidence Table Author, Year Study Design Country Intervention Category Specific Intervention Population … of treatment and the gains continued into the 2nd year. 35 Author, Year Study Design Country

449. Multiple-Sclerosis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/multiple-sclerosis_executive.pdf
     April 01, 2015 - A 2013 Cochrane overview review and network analysis of 44 2- to 3-year trials of DMTs for MS found … A complete description of the methods can be found in the full report. … Outcomes reported from unique studies included in the analytic set for long-term DMT use DMT and Author … Discontinuations tended to occur during the first or second year of the study. … Health care communication issues in multiple sclerosis: an interpretive description.

450. Transparency of Reporting Requirements: Management of Infertility (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
     September 02, 2016 - unmatched studies, we will conduct a manual match using the condition, intervention, sample size, and author … www.effectivehealthcare.ahrq.gov Published online: September 2, 2016 3 • Number of study arms • Intervention description … We will use author names and intervention terms to search for a matching publication in PubMed. … Form for Matching Study Variables Between Published Manuscript and CT.Gov Eligible Study Record*: Author … Last name, Publication Date (Month/Year), RefID CT.gov Identifier: NCT number CT.Gov Record Field

451. breast-biopsy-update-130920 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/breast-biopsy-update_research-protocol.pdf
     September 20, 2013 - and a large proportion will have biopsies.5, 6 More than a million women have breast biopsies each year … Author contact will be by email (to the corresponding author of each study), with a primary contact … features: lowest likelihood of confounding due to comparison to a randomized controlled group; a clear description … Ten-­‐year  risk  of  false  positive  screening  mammograms   and  clinical  breast

452. Finding Evidence for Comparing Medical Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-finding-evidence_methods.pdf
     January 01, 2011 - • Field searching, publication type, author, etc. … Evidence of effectiveness of the search strategy • Statement of any methodological filters used • Description … Stroke 2008 Aug;39(8):e139; author reply e40. 65. Suarez-Almazor ME, Belseck E, Homik J, et al. … Author contacts for retrieval of data for a meta-analysis on exercise and diet restriction. … , 2000 EMCare http://www.elsevier.com/wps/find/bibliographicdatab asedescription.cws_home/708272/description

453. Evidence-based Practice Center Systematic Review Protocol - Management of Infantile Epilepsies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-252-infantile-epilepsies-disposition-comments.pdf
     October 25, 2022 - management-infantile-epilepsy/research Published Online: October 25, 2022 3 Public Comments and Author … If future studies included pathology/seizure etiology not only in the description of included patients … For example, the first gene therapies for (infantile) epilepsy began this year, so they will be coming … pharmacological and dietary treatments remain unclear, since few studies followed patients for longer than one year … Response Public Comments and Author Response

454. Disposition of Comments_Blood-Based Tests for Multiple Cancer Screening: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cell-free-dna-disposition-comments.pdf
     May 14, 2025 - Published Online: May 14, 2025 2 Peer Reviewer, Technical Expert, and Public Comments and Author … In the textual description of results beginning on page 20, the results are similarly organized by … questions, the section on the logic model states that an evidence synthesis conducted within the coming year … number of cancers are diagnosed at late stages13, and more than 600,000 people die of cancer every year … Systematic Review Comments to Draft Report Peer Reviewer, Technical Expert, and Public Comments and Author

455. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/colorectal-cancer-screening_research-protocol.pdf
     May 18, 2011 - The following information will be extracted from each study, where applicable: author identification … , year of publication, source of study funding, study design characteristics, recruitment setting/patient-inclusion … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description

456. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gerd-disposition-120104.pdf
     April 01, 2011 - Peer Reviewer #6 Executive Summary Better description of applicability of evidence in the executive … They are approved for the symptom of frequent heartburn only up to 2 week courses x 3 in a year.” … In the appendix, it was noted that the study was rejected because it lacked a >5 year follow-up. … , have >5 year follow-up in 2010. 3- Other healing studies of 8 week duration without a >5 year follow-up … in patients who received high-dose, defined as multiple daily doses, and long-term PPI therapy (a year

457. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-careassociated-infections_research-protocol.pdf
     August 26, 2011 - Before and after the intervention, with followup to gauge the durability of the effect (minimum of 1 year … Amendments In the event of protocol amendments, the date of each amendment will be accompanied by a description … following elements should be included in reporting on the implementation of PSPs: An explicit description … chosen intervention components, and/or an explicit logic model for ―why this PSP should work.‖ A description … Handwashing systematic reviews (limited to English only) Handwashing[mh] AND systematic[sb] #S3 Author

458. CER 215 Adverse Effects of Pharmacologic Treatments of Major Depression in Older Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-215-depression-older-adults-comments.pdf
     March 28, 2019 - Peer reviewer #3 Executive Summary Executive summary: Page ES‐1, line 22: The description of the … The description in the methods has not been revised, as it is written in accordance with similar systematic … While this strategy has merit, it would be helpful to present in the results a summary description for … Including a description of cognitive status of the participants in the trials would be useful.

459. Disposition of Comments Report for The Patient-Centered Medical Home (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_disposition-comments.pdf
     July 03, 2012 - connotes an intervention like applying silver sulfadiazine cream to a burn, consistent with the authors' description … The pediatric medical home concept evolved over a 40-year period, informed by an increasingly rich body

460. S44 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - I heard they had decided on the 10 biggest hospitals getting funded 1 year, and the next year the next … 10, and the next year the next 10. … The scientific panel recommended a 1-year delay. … Our focus groups with clinicians revealed some discomfort with a delay of 1 year. … PharmaCare found the simplicity of the description very helpful.